• Treatment-focused longitudinal research reveals how access to care and modality choice shape long-term outcomes for narcotics addicts, with abstinence linked to stability and support; methadone maintenance and integrated programs emerge as key paradigms [1], [2], [10], [6], [7].

• Psychometric and personality-based approaches dominated early relapse research, using MMPI-derived scales and heroin-specific measures to differentiate relapsers, predict outcomes, and validate addiction constructs [4], [19], [17].

• Methadone-centered pharmacotherapy appears as a central strategy, with metabolic-disease framing, programmatic maintenance, and multi-modal delivery studied across short and medium-term follow-ups [6], [7], [14].

• Social, legal, and criminological contexts are examined through cross-national and urban samples, linking heroin addiction to crime, delinquency, policy, and population health in Britain, Brisbane, and urban settings [3], [16], [8], [15].

• Population-level measurement and definitional work, including operational definitions of drinking problems and population prevalence, highlight methodological diversity in assessing harm and exposure across groups [20], [12], [13], [8].